Pictet Asset Management Holding Sa Rhythm Pharmaceuticals, Inc. Transaction History
Pictet Asset Management Holding Sa
- $85.6 Billion
- Q2 2024
A detailed history of Pictet Asset Management Holding Sa transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 801,796 shares of RYTM stock, worth $41.2 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
801,796
Previous 1,211,679
33.83%
Holding current value
$41.2 Million
Previous $52.5 Million
37.3%
% of portfolio
0.04%
Previous 0.06%
Shares
3 transactions
Others Institutions Holding RYTM
# of Institutions
178Shares Held
69.1MCall Options Held
467KPut Options Held
224K-
Primecap Management CO Pasadena, CA7.31MShares$375 Million0.22% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$346 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY6.4MShares$329 Million3.49% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.08MShares$312 Million3.77% of portfolio
-
Goldman Sachs Group Inc New York, NY5.29MShares$272 Million0.04% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $2.86B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...